Journal of Microbiology, Immunology and Infection (Feb 2024)

Under-utilization of statins among people with HIV who were aged 40 years or older

  • Pei-Ying Wu,
  • Hsin-Yun Sun,
  • Yu-Shan Huang,
  • Wang-Da Liu,
  • Kuan-Yin Lin,
  • Yu-Zhen Luo,
  • Hsi-Yen Chang,
  • Ling-Ya Chen,
  • Yi-Ting Chen,
  • Chien-Ching Hung

Journal volume & issue
Vol. 57, no. 1
pp. 200 – 203

Abstract

Read online

From June 2022 to April 2023, 1629 HIV-positive participants were assessed for the risk of atherosclerotic cardiovascular disease (ASCVD). The 10-year ASCVD risk of <5 %, 5 % to <7.5 %, ≥7.5 % to <20 % and ≥20 % were 59.9 %, 14.4 %, 20.7 % and 5.0 %, respectively; 440 (27.0 %) participants met the criteria for statin therapy, but only 171 (38.8 %) were prescribed statins.

Keywords